Last price paid | 0.32 | |
Change | +3.23% [ +0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 23.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 10.11.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +54.76% |
Year to date (YTD) | +14.29% |
1 month | +52.38% |
3 months | +18.52% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.21 |
Underlying price on issue | 39.50 |
Premium | 0.02% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281039359 |
Symbol | IBI7ZZ |
Security | 128103935 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | BB Biotech N, CH0038389992 |
Underlying ISIN | CH0038389992 |
Funding level | 31.589800 |
Stop-loss level | 32.431400 |
Distance to stop-loss level | 25.79% |
Long/Short type | Long |
Subscription ratio | 40.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 08.11.2023 |
Premium | 2.04% |
Premium p.a. | n.a. |
Leverage | 3.36 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 12.110200 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
KUEHNE & NAGEL | 268.90 |
ABB Ltd | 49.39 |
Lonza Group | 521.40 |
Partners Group Ho... | 1'221.50 |
Holcim | 85.22 |
Name | Price |
---|---|
Givaudan | 4'130.00 |
ROCHE GS | 273.30 |
LOGITECH INT. | 79.88 |
Nestlé SA | 94.26 |
SWISSCOM N | 533.00 |